Why Do HIV Vaccine Trials Keep Failing?

Published on August 10, 2020

The writer discusses the implication of investing in large scale trials ; manufacturing and testing HIV vaccines that have little reasonable hope of efficacy. More comprehensive basic and preclinical research would enable scientists to identify approaches with a far better chance of success  and at much lower cost.

Other news

EARLY RELEASE: Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020

August 7, 2020
This report describes findings from an analysis of pediatric COVID-19 hospitalization data from 14 states during March-July, 2020.

Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross-sectional observational study

August 10, 2020
The researchers speculate that the regional effect is driven by increasing comorbidity burden in regions with lower levels of socioeconomic development. Pardo and Black Brazilians have, on average, less economic security, are less likely to be able to stay at home and work remotely, and comprise a substantial proportion of health and care workers. The Lancet Global Health